Skip to main content

Preop Intranasal Povidone-Iodine Reduces Rate of Surgical Site Infection

Medically reviewed by Carmen Pope, BPharm. Last updated on April 12, 2024.

By Elana Gotkine HealthDay Reporter

FRIDAY, April 12, 2024 -- Use of presurgery intranasal povidone-iodine (PVP-I) is effective for reducing the rate of surgical site infection (SSI) after joint arthroplasty and spine surgery, according to a study published online March 27 in the American Journal of Infection Control.

Lisa Saidel-Odes, M.D., from Ben-Gurion University of the Negev in Beer-Sheva, Israel, and colleagues conducted a retrospective case-control study designed to reduce SSI risk after joint arthroplasty and spine surgery by reducing Staphylococcus aureus colonization burden with PVP-I application in conjunction with skin antisepsis. The analyses included 688 adults who underwent joint arthroplasty or spine surgery during February 2018 through October 2021 (postintervention cohort) compared to a similar retrospective historical patient cohort from 2016 to 2017 (660 controls).

The researchers found that post-intranasal PVP-I, the eradication rate of S. aureus nasal colonization was 39.6 percent. Patients who were positive versus negative for S. aureus on 24-hour postsurgery nasal culture had a higher SSI rate. For all surgical procedures, the deep SSI rate per 100 operations decreased postintervention versus the historical cohort.

"Our study clearly shows that we can prevent surgical site infections and keep patients safer through the use of a simple presurgical nasal application of povidone-iodine in combination with standard chlorhexidine gluconate bathing," Saidel-Odes said in a statement. "An additional application of the povidone-iodine might be needed for patients with greater nasal colonization."

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted April 2024

Read this next

ASCO: Neoadjuvant Ipilimumab + Nivolumab Ups Survival in Resectable Melanoma

WEDNESDAY, June 5, 2024 -- Neoadjuvant ipilimumab plus nivolumab followed by surgery results in longer event-free survival than surgery followed by adjuvant nivolumab among...

Odds of Death Lower With Surgery for Hip Fracture in Patients With Dementia

MONDAY, June 3, 2024 -- For community-dwelling patients with dementia and fracture of the femoral head and neck, the odds of death are lower for those treated surgically...

Emergency Inguinal Hernia Surgery Rates Increased With Lower Country Income

FRIDAY, May 31, 2024 -- For patients undergoing inguinal hernia surgery, emergency surgery rates increase from high- to low-income countries, according to a study published online...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.